Early Diagnosis Of Alzheimers Disease
Download Early Diagnosis Of Alzheimers Disease full books in PDF, epub, and Kindle. Read online free Early Diagnosis Of Alzheimers Disease ebook anywhere anytime directly on your device. Fast Download speed and no annoying ads. We cannot guarantee that every ebooks is available!
Author | : Leonard F. M. Scinto |
Publisher | : Springer Science & Business Media |
Total Pages | : 366 |
Release | : 2000-02-09 |
Genre | : Medical |
ISBN | : 1592590055 |
Drs. Leonard Scinto and Kirk Daffner provide a comprehensive survey of new diagnostic approaches to Alzheimer's disease. The authoritative contributors critically survey the most promising current research on early diagnostic markers for Alzheimer's disease, including the elucidation of changes in the brain revealed by structural and functional neuroimaging, as well as the characteristic patterns of cognitive decline that are documented by sensitive neuropsychological tests, various genetic markers, and biological assays. Early Diagnosis of Alzheimer's Disease illuminates the complex issues surrounding the search for early markers of this increasingly widespread disease. It will establish a new standard reference guide for all those working with Alzheimer's patients.
Author | : Management Association, Information Resources |
Publisher | : IGI Global |
Total Pages | : 671 |
Release | : 2020-08-30 |
Genre | : Medical |
ISBN | : 1799834425 |
Cognitive impairment, through Alzheimer’s disease or other related forms of dementia, is a serious concern for afflicted individuals and their caregivers. Understanding patients’ mental states and combatting social stigmas are important considerations in caring for cognitively impaired individuals. Technology is playing an increasing role in the lives of the elderly. One of the most prevalent developments for the aging population is the use of technological innovations for intervention and treatment of individuals with mental impairments. Research Anthology on Diagnosing and Treating Neurocognitive Disorders examines the treatment, diagnosis, prevention, and therapeutic and technological interventions of neurodegenerative disorders. It also describes programs and strategies that professional and family caregivers can implement to engage and improve the quality of life of persons suffering from cognitive impairment. Highlighting a range of topics such as dementia, subjective wellbeing, and cognitive decline, this publication is an ideal reference source for speech pathologists, social workers, occupational therapists, psychologists, psychiatrists, neurologists, pediatricians, researchers, clinicians, and academicians seeking coverage on neurocognitive disorder identification and strategies for clinician support and therapies.
Author | : Amit Kumar Tyagi |
Publisher | : John Wiley & Sons |
Total Pages | : 532 |
Release | : 2021-08-24 |
Genre | : Computers |
ISBN | : 1119785723 |
The book details deep learning models like ANN, RNN, LSTM, in many industrial sectors such as transportation, healthcare, military, agriculture, with valid and effective results, which will help researchers find solutions to their deep learning research problems. We have entered the era of smart world devices, where robots or machines are being used in most applications to solve real-world problems. These smart machines/devices reduce the burden on doctors, which in turn make their lives easier and the lives of their patients better, thereby increasing patient longevity, which is the ultimate goal of computer vision. Therefore, the goal in writing this book is to attempt to provide complete information on reliable deep learning models required for e-healthcare applications. Ways in which deep learning can enhance healthcare images or text data for making useful decisions are discussed. Also presented are reliable deep learning models, such as neural networks, convolutional neural networks, backpropagation, and recurrent neural networks, which are increasingly being used in medical image processing, including for colorization of black and white X-ray images, automatic machine translation images, object classification in photographs/images (CT scans), character or useful generation (ECG), image caption generation, etc. Hence, reliable deep learning methods for the perception or production of better results are a necessity for highly effective e-healthcare applications. Currently, the most difficult data-related problem that needs to be solved concerns the rapid increase of data occurring each day via billions of smart devices. To address the growing amount of data in healthcare applications, challenges such as not having standard tools, efficient algorithms, and a sufficient number of skilled data scientists need to be overcome. Hence, there is growing interest in investigating deep learning models and their use in e-healthcare applications. Audience Researchers in artificial intelligence, big data, computer science, and electronic engineering, as well as industry engineers in transportation, healthcare, biomedicine, military, agriculture.
Author | : Marianne Boenink |
Publisher | : Springer |
Total Pages | : 300 |
Release | : 2016-09-13 |
Genre | : Social Science |
ISBN | : 1137540974 |
This book explores international biomedical research and development on the early diagnosis of Alzheimer's disease. It offers timely, multidisciplinary reflections on the social and ethical issues raised by promises of early diagnostics and asks under which conditions emerging diagnostic technologies can be considered a responsible innovation. The initial chapters in this edited volume provide an overview and a critical discussion of recent developments in biomedical research on Alzheimer's disease. Subsequent contributions explore the values at stake in current practices of dealing with Alzheimer's disease and dementia, both within and outside the biomedical domain. Novel diagnostic technologies for Alzheimer's disease emerge in a complex and shifting field, full of controversies. Innovating with care requires a precise mapping of how concepts, values and responsibilities are filled in through the confrontation of practices. In doing so, the volume offers a practice-based approach of responsible innovation that is also applicable to other fields of innovation.
Author | : Walter George Bradley |
Publisher | : |
Total Pages | : 1672 |
Release | : 2004 |
Genre | : Diagnosis |
ISBN | : 9780750674690 |
New edition, completely rewritten, with new chapters on endovascular surgery and mitochrondrial and ion channel disorders.
Author | : Tapan Khan |
Publisher | : Academic Press |
Total Pages | : 278 |
Release | : 2016-08-02 |
Genre | : Psychology |
ISBN | : 0128051477 |
Biomarkers in Alzheimer's Disease provides a comprehensive overview of all modalities of Alzheimer's disease biomarkers, including neuroimaging, cerebrospinal fluid, genomic, and peripheral systems. Each chapter integrates molecular/cellular abnormality due to Alzheimer's disease and technological advancement of biomarkers techniques. The book is ideal for clinical neuroscience and molecular/cellular neuroscience researchers, psychiatrists, and allied healthcare practitioners involved in the diagnosis and management of patients with cognitive impairment and Alzheimer's disease, and for differential diagnosis of Alzheimer's disease with other non-Alzheimer's dementia. - Presents a comprehensive overview detailing all modalities of Alzheimer's disease biomarkers - Written for neuroscience researchers and clinicians studying or treating patients with Alzheimer's Disease - Integrates, in each chapter, the molecular/cellular abnormality due to Alzheimer's disease and the technological advancement of biomarkers techniques
Author | : Ahmed Moustafa |
Publisher | : Academic Press |
Total Pages | : 256 |
Release | : 2021-08-28 |
Genre | : Psychology |
ISBN | : 0128213353 |
Nearly 44 million people have Alzheimer's or related dementia worldwide, according to the Alzheimer's Disease International organization. That number is expected to double every 20 years. Unlike other books on the market, Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy covers recent advancements in cognitive, clinical, neural, and therapeutic aspects of Alzheimer's and other forms of dementia.First, readers are introduced to cognitive and clinical studies, focusing on the different types of memory impairment, past and future thinking. This includes the prevalence of depression, its relationship to other symptoms, and the quality of life for those with Alzheimer's disease. In addition, the book discusses recent studies on memory dysfunction in advanced-stage Alzheimer's disease, in comparison to early-stage, including a chapter on the underlying factors in the transition from mild cognitive impairment to Alzheimer's diagnosis. Following this section, the book presents recent studies on the role of different cortical and subcortical structures in the development of various symptoms in Alzheimer's disease, as well as different neural biomarkers underlying the development and treatment of the disease. In the last section of the book, therapeutic aspects of Alzheimer's disease, focusing on behavioral and pharmacological treatments of sleep disorders, memory problems, and depression, are reviewed. The book aids readers in understanding the advances in research and care, making it a prime tool for all clinicians, psychologists, researchers, neurologists, and caregivers of dementia patients. - Reviews recent developments of cognitive and clinical studies - Covers factors underlying the transition from mild cognitive impairment to Alzheimer's disease - Discusses different neural biomarkers underlying the development and treatment of Alzheimer's disease - Provides a comparison of the effectiveness of various types of treatments
Author | : Jeffrey M. Burns |
Publisher | : John Wiley & Sons |
Total Pages | : 168 |
Release | : 2008-05-27 |
Genre | : Medical |
ISBN | : |
Written by leading authorities in the field, this book describes the cognitive changes associated with age, the earliest detectable stages of Alzheimer’s, and the relationship of these conditions to MCI. The authors review the latest advances in our understanding of MCI, its prevalence, evaluation, management, and outcomes and in so doing provide practising physicians with a useful resource that assists them in identifying those MCI patients who will progress to recognised Alzheimer’s Disease. Beautifully presented in full colour, Early Diagnosis and Treatment of Mild Cognitive Impairment includes case studies and discusses future therapeutic and diagnostic strategies. It is an invaluable resource for postgraduates and professionals, for specialist physicians in neurology and psychiatric medicine, geriatric medicine and general practice.
Author | : Charlotte E. Teunissen |
Publisher | : Humana |
Total Pages | : 236 |
Release | : 2022-05-19 |
Genre | : Medical |
ISBN | : 9781071613214 |
This volume covers the latest methods used in clinical neurochemistry laboratories for both clinical practice and research. Chapters in this book discuss topics such as techniques for cerebrospinal fluid (CSF) collection, pre-analytical processing, and basic CSF analysis; an examination of biomarkers including ELISA and automated immunochemical assays for amyloid and tau markers for Alzheimer’s disease; the analysis of neurofilaments by digital ELISA; and an example of successful novel immunoassay development. In the Neuromethods series style, chapters include the kind of detail and key advice from the specialists needed to get successful results in your laboratory. Cutting-edge and thorough, Cerebrospinal Fluid Biomarkers is a valuable resource for clinicians and researchers to use in CSF labs and CSF courses.
Author | : Jason Karlawish |
Publisher | : St. Martin's Press |
Total Pages | : 269 |
Release | : 2021-02-23 |
Genre | : Health & Fitness |
ISBN | : 1250218748 |
A definitive and compelling book on one of today's most prevalent illnesses. In 2020, an estimated 5.8 million Americans had Alzheimer’s, and more than half a million died because of the disease and its devastating complications. 16 million caregivers are responsible for paying as much as half of the $226 billion annual costs of their care. As more people live beyond their seventies and eighties, the number of patients will rise to an estimated 13.8 million by 2050. Part case studies, part meditation on the past, present and future of the disease, The Problem of Alzheimer's traces Alzheimer’s from its beginnings to its recognition as a crisis. While it is an unambiguous account of decades of missed opportunities and our health care systems’ failures to take action, it tells the story of the biomedical breakthroughs that may allow Alzheimer’s to finally be prevented and treated by medicine and also presents an argument for how we can live with dementia: the ways patients can reclaim their autonomy and redefine their sense of self, how families can support their loved ones, and the innovative reforms we can make as a society that would give caregivers and patients better quality of life. Rich in science, history, and characters, The Problem of Alzheimer's takes us inside laboratories, patients' homes, caregivers’ support groups, progressive care communities, and Jason Karlawish's own practice at the Penn Memory Center.